5 Things to Know Ahead of the Opening Bell 3/11/2026

0:28Your data lives everywhere. and a really smart one you can set? Earning cash back on what you buy every day. And with Discover, you can. Get this. Discover automatically matches all the cash back you've earned at the end of your first year. Seriously, all of it. And we trust you to make smart decisions. After all, you listen to this show. See terms at discover.com slash credit card. Hi, I'm Becky Quick, co-host of Squawk Box. And this is five things you need to know before today's opening bell. Chevron and Shell reportedly nearing the first big production deals with Venezuela since the United States captured the country's leader, Nicolas Maduro, back in January.

1:11Disney naming the president of its Disneyland Resort the next chair of the company's division overseeing theme parks, cruise ships, resort hotels, and consumer products. Thomas Maslum will succeed Josh DeMauro, who takes over as Disney CEO next week. Senate aides have reportedly been given approval to use three AI chatbots for official work. The New York Times says that the list consists of Google's Gemini Chat, OpenAI's ChatGPT, and Microsoft's Copilot. And the Trump administration is restarting the global entry program today, weeks after it paused that program because of the partial government shutdown.

1:48Global entry allows American citizens expedited processing when they return to the United States from abroad. And the IPO of SoftBank's Japanese payment app, PayPay, is expected to price near the low end of its marketing range of$17 to$20 a share. Reuters says that pricing will be finalized after the closing bell. PayPay plans to list on the Nasdaq under the symbol PayPay. Pizza. PayPay. JoJo. We'll be back later today with Squawk Pod, our daily podcast featuring the best of Squawk Box. Stay tuned to your feed wherever you get your podcasts and listen anytime.

2:51physical activity to help adults with moderate to severe obstructive sleep apnea, OSA, and obesity to improve their OSA. ZetBound is approved as a 2.5, 5, 7.5, 10, 12.5, or 15 milligram injection. ZetBound contains terzepatide and should not be used with other terzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if ZetBound is safe and effective for use in children. Don't share needles or pins or reuse needles. Don't take if allergic to it, or if you or someone in your family had medullary thyroid cancer, or if you've had multiple endocrine neoplasia syndrome type 2.

3:27Tell your doctor if you get a lump or swelling in your neck. Stop sepbound and call your doctor if you have severe stomach pain or a serious allergic reaction. Severe side effects may include inflamed pancreas or gallbladder problems. Tell your doctor if you experienced vision changes before scheduled procedures with anesthesia, if you're nursing, pregnant, plan-to-be, or taking birth control pills. Taking ZipBound with a sulfonylurea or insulin may cause low blood sugar. Side effects include nausea, diarrhea, and vomiting, which can cause dehydration and worsen kidney problems. Talk to your doctor.

3:57Call 1-800-545-5979 or visit zipbound.lily.com.